title: The importance of comparative oncology in translational medicine.
abstract: Human cancer is so complex that in vivo preclinical models are needed if effective therapies are to be developed. Naturally occurring cancers in companion animals are therefore a great resource, as shown by the remarkable growth that comparative oncology has seen over the last 30 years. Cancer has become a leading cause of death in companion animals now that more pets are living long enough to develop the disease. Furthermore, more owners are seeking advanced and novel therapies for their pets as they are very much considered family members. Living in the same environments, pets and humans are often afflicted by the same types of cancer which show similar behavior and, in some species, express the same antigen molecules. The treatment of pet tumors using novel therapies is of compelling translational significance.
authors.affiliation: Department of Molecular Biotechnologies and Health Sciences, Molecular Biotechnology Center, University of Turin, Via Nizza, 52, 10126, Turin, Italy.
authors.forename: Federica
authors.initials: F
authors.lastname: Riccardo
authors.forename: Luigi
authors.initials: L
authors.lastname: Aurisicchio
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Impellizeri
authors.forename: Federica
authors.initials: F
authors.lastname: Cavallo
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D007109:Immunity; D007167:Immunotherapy; D009369:Neoplasms / Q000209:etiology* / Q000628:therapy*; D057170:Translational Research, Biomedical